China, US de­velop new MERS treat­ment

Asian Journal - - World -

Bei­jing: Chi­nese and Amer­i­can sci­en­tists have jointly de­vel­oped a new an­ti­body tar­get­ing the Mid­dle East Res­pi­ra­tory Syn­drome (MERS) virus, which has claimed the lives of 16 peo­ple and in­fected 150 oth­ers in the re­cent out­break in South Korea. Shang­hai’s Fu­dan Univer­sity, which worked with US Na­tional In­sti­tutes of Health to de­velop the an­ti­body, on Mon­day said tests on an­i­mals have seen “very ef­fec­tive” re­sults, Xin­hua news agency re­ported. Jiang Shibo, who led the re­search team at Fu­dan, said the m336 an­ti­body could neu­tralise MERS virus more ef­fec­tively than other an­ti­bod­ies. Zhong Nan­shan, a renowned res­pi­ra­tory ex­pert, called for an im­me­di­ate clin­i­cal trial. The m336 an­ti­body treat­ment has proved more ef­fec­tive when cou­pled with a spe­cific type of polypep­tide, Jiang added.

Newspapers in English

Newspapers from Canada

© PressReader. All rights reserved.